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Abstract
Background: Palliative care was initially developed for patients with advanced cancer. Over the past years,
however, palliative care has broadened its focus from terminal cancer patients to patients with other serious,
life-limiting illnesses. Nevertheless, the identification of palliative care needs (PCNs) among hospital patients remains
an insufficiently investigated topic of research. The aim of our study was to describe the characteristics of hospital
patients with palliative care needs and to develop a score for their identification.
Methods: We conducted an epidemiological study. Data were collected prospectively from inpatients at the
University Medical Center Freiburg, Germany. For each patient discharged from a hospital ward, the treating
physician had to report whether the patient had PCNs or not. The response rate was 96 %, and data from 39,849
patients could be analyzed. A binary logistic regression analysis was performed in order to identify risk factors for
developing PCNs and to develop a predictive score for the identification of patients with PCNs upon their
admission to the hospital. In order to validate the risk prediction model, we used a bootstrap analysis.
Results: During the study period, 6.9 % (2757) of all patients had palliative care needs. Only 56 of them (2 %)
received palliative treatment. Binary logistic regression analysis showed that older patients without relatives who
suffered from metastatic cancer and/or liver cirrhosis had the highest risk of developing palliative care needs
(PCN-score; sensitivity: 0.815; specificity: 0.640).
Conclusions: Given the aging population and associated increase in the number of patients requiring palliative
care, it is crucial to detect palliative care needs in hospital patients with both cancerous and non-cancerous
life-limiting diseases. Our predictive score contributes to the identification of palliative care needs in patients with
life-limiting diseases, which allows physicians to take the appropriate therapeutic steps.
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Background
In industrialized countries, 75 % of deaths are caused by
progressive advanced chronic diseases [1]. Furthermore, it
is estimated that 63 % of those who die may need pallia-
tive care [2]. We are faced with an aging population that is
expected to age even further in the future [3]. In 2009,
17 % of Europe’s total population was aged ≥ 65 years. Ex-
perts predict that this age group will account for 29 % of
all European citizens by 2050 [4]. In light of these figures,
we assume that the prevalence of advanced malignancies
and chronic diseases will continually increase. Therefore,
one can also expect a growing number of patients in need
of end-of-life care [5].
The medical focus of palliative care is symptom-related
treatment aimed at reducing pain, physically burdensome
symptoms (e.g., dyspnea, nausea), and psychological afflic-
tions (e.g., depression). Rather than prolonging life, treat-
ment aims at enhancing quality of life (QoL). Palliative
care is a comprehensive therapeutic approach that encom-
passes the treatment of physical symptoms as well as the
integration of psychological, social, and spiritual needs of
both patients and their relatives. Ideally, palliative care
should be implemented as soon as an incurable disease is
diagnosed, not only in the imminent terminal phase [6].
Palliative care was initially developed for patients with
advanced cancer and an increasing number of cancer
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patients receive palliative care alongside standard oncol-
ogy care. However, it cannot be denied that other patients
are also in need of palliative care. Over the past years, pal-
liative care has broadened its focus from terminal cancer
patients to patients with other serious, life-limiting ill-
nesses [7], such as terminal cardiac, hepatic, or respiratory
insufficiency, human immunodeficiency virus (HIV), or
amyotrophic lateral sclerosis (ALS).
Nevertheless, the identification of palliative care needs
(PCNs) in hospital patients remains an insufficiently in-
vestigated topic of research. Therefore, the main goals of
our study were to describe the characteristics of hospital
patients with PCNs, to identify risk factors for the devel-




Data were collected prospectively from patients at the
University Medical Center Freiburg (UMCF), Germany,
one of the largest hospitals in Europe, with a total of
1479 hospital beds in 42 clinical departments. Sampling
took place from January 2004 to May 2005. At the time
of the study, the hospital had no specialized palliative
care service for in-house consultations and no palliative
care unit.
For each patient discharged or transferred from a
UMCF ward or deceased, electronic data sampling by the
attending physician was mandatory. For the purposes of
our study, we modified the file mask of the electronic dis-
charge management by adding the dichotomous question:
“Does or did this patient have palliative care needs?” For
each patient, this question had to be answered by the
treating physician responsible for discharge management.
When the physician clicked on the question, a text box
appeared explaining how PCN was defined using the
WHO definition: “Palliative care is the active total care of
patients whose disease is not responsive to curative treat-
ment. Control of pain, of other symptoms, and of psycho-
logical, social, and spiritual problems is paramount.” [8]
Some aspects of palliative care needs (e.g., pain, fatigue,
dyspnoea, nausea/vomiting, constipation, anxiety, and
depression) were also specified in the text box. Without
answering the question about PCN, the electronic dis-
charge management could not be completed, thereby
guaranteeing a nearly 100 % response rate.
During the study period, data were collected from
100,679 records. Data collection also included patients
who were transferred to another ward or another depart-
ment within the hospital. To prevent a bias toward pa-
tients who had longer hospital stays and were transferred
to different wards several times, only the data from the
last ward before leaving the hospital were included. This
limited data to 39,849 cases. If a patient had two or more
hospital stays during the observation period, we analyzed
each hospital stay separately. As a result, a total of 39,849
hospital stays were analyzed for 26,767 different patients
treated in the clinic. A total of 13,082 (32.8 % of 39,849)
cases resulted from readmissions.
Patients who died during their hospital stay were in-
cluded in our data.
Details of the study design are described elsewhere [5].
Study questions and statistical analyses
The main outcome measures of the study were the iden-
tification of the percentage of patients with PCNs in a
large acute care hospital and the development of a score
for their identification.
Data were analyzed with SPSS software (IBM SPSS for
Windows, Version 21.0). The t-test was used for interval
scaled variables; associations between dichotomous vari-
ables were tested with the χ2 statistic. In addition, a binary
logistic regression analysis was performed in order to
identify risk factors for developing PCNs and to develop a
predictive score for the identification of patients with
PCNs upon their admission to the hospital. The resulting
score was interpreted as the estimated probability that a
patient develops PCNs. Patients’ PCN status could be di-
vided into two groups (yes or no). Based on variation of
the cutoff, pairs of false positive rate (1-specificity) and
true positive rate (sensitivity) were presented in a receiver
operating characteristic (ROC) curve. In order to validate
the risk prediction model, we used a bootstrap analysis,
i.e., repeated sampling with replacement and modeling [9].
All tests were two-tailed, and p < .05 was considered
statistically significant.
Ethics
The study protocol was approved by the Ethics Committee
of the University Medical Center Freiburg and the data se-
curity official. Patients gave written consent to use their
routinely collected data for scientific purposes. Regulations
of the European Data Protection Directive [10] were
followed. The study was conducted according to the
Declaration of Helsinki [11].
Results
Patients with PCNs and their characteristics
During the study period, 6.9 % of all patients (2757/
39,849) had PCNs. Patient characteristics such as the
presence of PCNs, number of days in the hospital, and
palliative treatment as a part of their therapy are listed
in Table 1.
Only 56 out of 2757 patients (2 %) with PCNs received
palliative treatment in the sense of non-curative, disease-
modifying therapies such as palliative radiation therapy
or the palliation of breathlessness in advanced COPD.
Patients with PCNs were significantly older than those
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without (p < .001) and stayed on average 3.5 days longer
in the hospital. Significantly more patients with PCNs
died during their hospital stay than those without (4.5 %
v 2.5 %; p < .001) (Table 1). The proportion of patients
with and without PCNs and the frequency of PCNs in
each diagnostic group are shown in Table 2.
According to our data, the majority of patients with
PCNs had cancer (66.6 %, 1,836/2757). The prevalence
of PCNs was highest in patients with metastases (25.1 %,
1068/4256), malignant neoplasm (15.8 %, 1836/11,584),
anemia (13.5 %, 373/2772), acute renal failure (12.9 %, 99/
769), liver cirrhosis (12.3 %, 122/990), and/or dementia
(12.2 %, 58/474). In contrast, patients with cardiomyop-
athy (7.9 %, 59/750), coronary heart disease (6.9 %, 436/
6276), or apoplectic insult (i.e. intracerebral hemorrhage,
cerebral infarction, stroke, or sequelae of cerebrovascular
disease) (4.4 %, 74/1687) had a lower rate of PCNs.
Binary logistic regression analyses
In order to identify risk factors for developing PCNs and
to develop a score for the identification of patients with
PCNs, we conducted a binary logistic regression analysis.
In the regression model, we included sex, age, incurable
illnesses ranking among the top reasons for mortality [12],
and sociological factors such as the presence/absence of
relatives.
When a patient is admitted to the hospital, informa-
tion on all variables included (as mentioned above)
should be available. Therefore, data concerning therapy
and discharge were not included. Since the patient’s level
of care at admission was only registered in 23,851 cases,
a high level of care (summary of level of care at admis-
sion ≥ 5) was not taken into consideration here.
The regression analysis (based on the initial set of vari-
ables) showed that a diagnosis of cancer was the highest
risk factor for developing PCNs, with an odds ratio of
3.45. Furthermore, scoring positive for metastases con-
tributed to an increased risk by a factor of 3.29. The
third greatest risk factor was dementia, followed by HIV
and liver cirrhosis. Based on the entire sample with
Table 1 Patient characteristics, palliative treatment, hospital






Patients, N (%) 2757 (6.9) 37,092 (93.1)
Age in years, mean ± SD 63.8 ± 14.5 56.5 ± 18.1 <.001
Male patients, N (%) 1569 (56.9) 20,207 (54.5) .013
Presence of relatives, N (%) 1596 (57.9) 22,287 (60.1) .023
Palliative treatment, N (%) 56 (2.0) 60 (0.2) <.001
Hospital stay in days, mean ± SD 12.1 ± 14.6 8.6 ± 10.7 <.001
Deceased, N (%) 125 (4.5) 940 (2.5) <.001
Discharged home, N (%) 2086 (75.7) 30,472 (82.2) <.001
Discharged to another acute
care hospital or rehabilitation
center, N (%)
460 (16.7) 4844 (13.1) <.001
Discharged elsewhere
(e.g. nursing home), N (%)
86 (3.1) 836 (2.3) .004
Abbreviations: PCN palliative care need, SD standard deviation





p Proportion of patients
with PCNs relative to all patients
of diagnostic group (%)N (%) N (%)
Metastases 1068 (38.7) 3188 (8.6) <.001 25.1
Cancer 1836 (66.6) 9748 (26.3) <.001 15.8
Anemia 373 (13.5) 2399 (6.5) <.001 13.5
Acute renal failure 99 (3.6) 670 (1.8) <.001 12.9
Liver cirrhosis 122 (4.4) 868 (2.3) <.001 12.3
Dementia 58 (2.1) 416 (1.1) <.001 12.2
Depression 107 (3.9) 999 (2.7) <.001 9.7
Chronic renal failure 283 (10.3) 2667 (7.2) <.001 9.6
AIDS/HIV 11 (0.4) 103 (0.3) .250 9.6
Chronic heart failure 178 (6.5) 1692 (4.6) <.001 9.5
Diabetes mellitus 302 (11.0) 3537 (9.5) .015 7.9
COPD 132 (4.8) 1323 (3.6) .001 9.1
Cardiomyopathy 59 (2.1) 691 (1.9) .302 7.9
Coronary heart disease 436 (15.8) 5840 (15.7) .923 6.9
Apoplectic insult 74 (2.7) 1613 (4.3) <.001 4.4
Note that the percentages in the first two columns do not equal 100 %, as diagnostic groups are not disjunctive
Abbreviations: PCN palliative care need
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39,849 cases, Table 3 shows the initial model with all
variables included in the regression analysis.
A second analysis of the data, including the level of
care (23,851 cases), showed that a high level of care at
admission was a highly significant risk factor for PCNs,
which was to be expected. With regard to significance, a
high level of care ranked third in the list of potential risk
factors (odds ratio 2.17; 95 % CI, 1.92 to 2.45; p < .001).
In order to develop a manageable and easy to compute
predictive score for the identification of PCNs in hos-
pital patients, we calculated the final model (based on
these 23,851 cases), only taking into account the six
most important risk factors that were included in the
binary logistic regression analysis with forward selection
by step 1 to step 6 (cancer, metastases, age, absence of
relatives, liver cirrhosis, and high level of care at admis-
sion). After step 6 the improvements in the explained
variance (Nagelkerkes R2) were minimal. Because we
were interested in having a sparse model to avoid over-
fitting, we restricted our score to these first six variables.
Table 4 shows the equation of the model with the re-
gression coefficients and standard errors.
The distribution of parameters after conducting 1000
bootstrap replications showed a close agreement be-
tween the original data set and the bootstrap results
(data not shown). Figure 1 illustrates the results of the
regression analysis using an ROC curve.
The area under the curve (AUC) represents the prob-
ability that the assay result for a randomly chosen
positive case will exceed the result for a randomly
chosen negative case. The AUC was calculated at 0.807
(p < .001; 95 % CI, 0.795 to 0.819). To ensure a good
sensitivity, we chose 0.04 as the cutoff point, which led
to a sensitivity of 0.815 and a specificity of 0.640. Thus,
approximately 81.5 % of all patients with PCNs would be
correctly identified as such, and 36.0 % of all patients
without PCNs would be incorrectly identified as having
PCNs.
Due to the low prevalence of 6.9 %, the positive pre-
dictive value was low (14.4 %), while the negative pre-
dictive value was high (97.9 %), which emphasizes the
envisaged role of the score as a "rule out" test for PCN
(predictive values calculated via Bayes' theorem).
Our results showed that older patients without rela-
tives who have a high level of care at admission and suf-
fer from metastatic cancer and/or liver cirrhosis had the
highest risk of developing PCNs.
Discussion
According to the World Health Organization (WHO),
palliative care represents “an approach that improves the
quality of life of patients and their families facing the
problems associated with life-threatening illness, through
the prevention and relief of suffering by means of early
identification and impeccable assessment and treatment
of pain and other problems, physical, psychosocial and
spiritual” [6]. Thus, palliative care primarily aims at im-
proving QoL of both patients with incurable diseases and
their relatives. Erroneously, palliative care is often reduced
to end-of-life care [13, 14]. It is also predominantly offered
only after life-prolonging treatment has failed [15]. How-
ever, a substantial number of patients with incurable dis-
eases suffer from a number of physically distressing
symptoms (i.e. pain) as well as psychosocial and spiritual
burden. This suffering may be overlooked if only life-
prolonging therapy is offered [16]. There is substantial evi-
dence that the integration of palliative care – either in
combination with standard care or as the main focus of
care – leads to better patient and caregiver outcomes and
a reduced use of futile intensive care [13]. Therefore, a
shift from the continued use of ineffective therapies to a
focus on palliative care and the relief of symptoms
throughout the course of illness is widely encouraged [16].
For patients with non-small cell lung cancer (NSCLC),
Temel et al. [17] showed that early palliative care (EPC)
improved patients’ QoL, reduced the incidence of depres-
sion, and decreased the number of aggressive (and gener-
ally futile) therapies at the end of life. In addition, EPC
increased patients’ survival time [17]. In a randomized
study with patients suffering from different cancer entities,
Zimmermann et al. [18] found that patients who received
EPC not only had a better QoL but also a higher level of
Table 3 Risk factors for developing palliative care needs (PCNs)
Risk factor N Odds ratio (95 % CI) p
Cancer 11,584 3.45 (3.10 – 3.84) <.001
Metastases 4256 3.29 (2.96 – 3.65) <.001
AIDS/HIV 114 3.23 (1.69 – 6.16) <.001
Dementia 474 2.12 (1.58 – 2.85) <.001
Liver cirrhosis 990 2.06 (1.67 – 2.53) <.001
Acute renal failure 769 1.88 (1.50 – 2.36) <.001
Absence of relatives 15,966 1.52 (1.39 – 1.65) <.001
Chronic heart failure 1870 1.52 (1.27 – 1.81) <.001
Anemia 2772 1.49 (1.32 – 1.69) <.001
Depression 1106 1.49 (1.20 – 1.85) <.001
Cardiomyopathy 750 1.41 (1.05 – 1.88) .021
Chronic renal failure 2950 1.26 (1.09 – 1.45) .001
Coronary heart disease 6276 1.14 (1.02 – 1.29) .028
Sex: female 18,073 1.03 (0.95 – 1.13) .442
Age [1/y] 39,849 1.02 (1.02 – 1.02) <.001
Diabetes mellitus 3839 0.97 (0.85 – 1.11) .674
COPD 1455 0.97 (0.80 – 1.18) .788
Apoplectic insult 1687 0.84 (0.65 – 1.07) .151
Data base: N = 39,849
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satisfaction with their treatment compared to those in the
control group, who were not offered EPC.
One of the main goals of our study was to identify the
percentage of patients with PCNs in a large acute care
hospital and to describe their characteristics. Our results
showed that predominantly but not exclusively patients
with metastatic cancer had a high risk of developing
PCNs. However, patients with other non-cancerous ill-
nesses were also in need of palliative care. For over
15 years, experts have been promoting the idea that pallia-
tive care should be provided on the basis of need rather
than diagnosis [19]. In light of such demands, the findings
of our study confront us with rather alarming figures; only
2 % of patients with PCNs actually received palliative
treatment, in 98 % these needs remained unmet.
Another focus of our study was the development of a
predictive score to aid in the identification of PCNs. We
hope that the score aims at increasing physicians’
awareness of palliative care needs – without being asked
explicitly: “Does this patient have a palliative care need?”
Our results showed that older patients without relatives
who had a high level of care at admission and suffered
from metastatic cancer and/or liver cirrhosis had the
highest risk of developing PCNs. With a sensitivity of
0.815 and a specificity of 0.640, this score is not optimal
and it remains unclear how to deal with patients whose
PCNs either are not identified or are falsely identified.
One simple and obvious solution to this problem is to
ask patients directly whether or not they perceive a need
for specialized (palliative) care (i.e., treatment of pain
and other problems, physical, psychosocial and spiritual
[6]) in addition to standard care.
Overall, our regression models confirmed the general
hypothesis that PCNs are largely found in patients with
cancerous diseases, particularly in the metastatic stage
[20]. However, patients who suffer from severe chronic
diseases (e.g. liver cirrhosis, AIDS-HIV or renal failure)
and have a very poor general condition and a high need
of care are also at risk of developing PCNs. Furthermore,
the absence of relatives and the presence of psycho-
logical ailments like dementia and depression were
shown to be clear risk factors, which underlines the im-
portance of psychosocial issues in palliative care.
Limitations
Our study had a number of inherent limitations. Our
data are about 10 years old, and at the time of the study,
the hospital had no specialized palliative care service for
in-house consultations and no palliative care unit. Now-
adays, an increasing number of patients –above all can-
cer patients – receive palliative care alongside standard
care. Today, physicians’ awareness of patients’ PCNs is
higher than 10 years ago, and if asked again, they would
probably identify more patients with PCNs.
Furthermore, we asked the treating physician about
patients’ PCNs and not the patient himself or his/her
Table 4 Predictive score – equation of the model
Variables Regression
coefficient B
Standard error Wald p Exp(B) 95 % confidence interval
exp(B)
lowest highest
Cancer (x1) 1.502 .074 406.934 .000 4.490 3.880 5.196
Metastases (x2) 1.054 .079 178.327 .000 2.870 2.458 3.350
Age [1/y] (x3) 0.026 .002 154.769 .000 1.026 1.022 1.030
Absence of relatives (x4) 0.421 .062 46.160 .000 1.523 1.349 1.720
Liver cirrhosis (x5) 0.895 .132 46.176 .000 2.448 1.891 3.169
High level of care (x6) 0.809 .062 172.559 .000 2.245 1.990 2.533
Constant −5.762 .147 1542.663 .000 .003
Equation
(Nagelkerkes R2: 0.199)
p ¼ 1 = 1þ e−zð Þ
z ¼ −5:762 þ 1:502  x1þ 1:054  x2þ 0:026  x3þ 0:421  x4þ 0:895  x5þ 0:809  x6
Fig. 1 Receiver operating characteristic (ROC) curve
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relatives. As we conducted an epidemiologic study with
close to 40,000 patients, the latter was not possible. This
might be a source of bias and a second reason why the
rate of PCNs might have been underestimated.
A current study quantified the number of hospital pa-
tients who are within the last year of life by connecting
data from the hospital system with national death regis-
tration data [21]. The authors identified about a third of
hospital inpatients who have entered the last year of
their lives. However, [21] was a prevalent cohort study
and thus prone to length-biased sampling, meaning that
patients with longer hospital stays were more likely to
be sampled. Using this design, mortality is likely to be
overestimated, as the length of hospital stay is associated
with disease severity, mortality and PCNs.
A definition of PCNs is complex because palliative
care can be divided into two levels. First, there is general
palliative care that can be provided by generalists in
their daily work. Second, there are specialist palliative
care physicians and nurses who are trained specifically
to handle complex palliative situations. To keep the sur-
vey clear and simple, we intentionally used the widely
accepted WHO definition of palliative care [22] without
differentiating between a primary and a secondary level
of palliative care. To what extent generalists may satisfy
basic needs for palliative care and how much specialist
palliative care is needed for complex situations cannot
be answered by our data.
In the database, patients with multiple stays in the
hospital were analyzed as separate cases. This may have
been a source of bias. Conversely, though, analyzing
multiple stays of the same person as only one case could
also present a source of bias. Which stay should be
regarded as the relevant one? In order to more accur-
ately calculate the number of beds needed for patients
with PCNs, we decided to analyze multiple stays as
independent.
With regard to our predictive score, we must acknow-
ledge certain limitations. The risk prediction model was
developed using the same data set that it was applied to
afterwards. It is well known that this leads to overfitting,
meaning that the explained variance may be overesti-
mated and the appraised predictive ability of the model
may be too high. To investigate the predictive ability of
our score, we conducted a bootstrap analysis. With re-
spect to the estimated standard errors, we found close
agreement between the original data set and the boot-
strap results. Thus, it appears unnecessary to doubt the
risk prediction model obtained in the original analysis.
We chose 0.04 as our cutoff point, meaning that a patient
is deemed to be in need of palliative care if his/her prob-
ability score exceeds 0.04. This seemingly low threshold
was due to the low prevalence of 6.9 % and the desire for
high sensitivity at a low cost to specificity. This, however,
may procure overestimated sensitivity and specificity, and
conceivably our predictive score may be less perfect for fu-
ture patients.
Prediction models in medicine have gained substan-
tially more importance in recent years, and health care
providers and policy makers are increasingly recom-
mending the use of prediction models [23]. Above all,
our predictive score aims at increasing the awareness of
PCNs in patients with cancerous and non-cancerous life-
threatening diseases. To what extent this score can be ap-
plied in the clinical setting and how it actually influences
clinicians’ decision making and behavior as well as patient
outcomes should be evaluated in further studies.
Conclusion
Given the aging population and associated increase in the
number of patients requiring palliative care [24], it is cru-
cial that PCNs are detected in patients with cancerous and
non-cancerous life-threatening diseases. In general, such
patients are likely to suffer from pain, dyspnea, and other
burdensome physical symptoms and require psychosocial
or spiritual support in the course of their progressing dis-
ease [25]. These patients are in need of palliative care not
only in the final months of their life but throughout the
course of their disease.
Our predictive score contributes to the identification
of PCNs in patients with life-limiting diseases, which al-
lows physicians to take appropriate therapeutic steps.
This not only involves pain and symptom management
but also attention to psychosocial and spiritual needs,
such as being treated as a “whole person”, preparation
for death, and achieving a sense of completion.
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